UA-158899894-1
Print Page | Contact Us | Report Abuse | Sign In | Register
Poster Submission

SBMT 17th Annual World Congress (2020) Call for Abstracts/Posters/ is now OPEN!

Submission deadline extended to March 5th, 2020!

 

The SBMT Scientific Committee invites you to submit a Poster abstract for the 2020 Annual World Congress, to be held March 20th to March 22nd 2020, Los Angeles, CA USA. Be a part of this cutting-edge conference on the forefront of science and technology in the fields of:

Artificial Intelligence (AI)Brain 
Connectomes
Brain-Computer
Interfaces
Brain 
Health
Concussion 
from blast & sports
EngineeringMolecular 
Biology
Nano-BioelectronicsNano-NeurosciencesNano-Neurosurgery
Neuro-Degenerative
diseases
(e.g., Alzheimer's, Parkinson's, &CTE)
Neuro-ImagingNeurologyNeuro-PhotonicsNeuro-Oncology

Neuroscience

Neuro-Trauma
and its specific impact on military personnel
Post-traumatic Stress Disorders 
(PTSD)
PsychiatryPsychology
RadiologyRadiation
Oncology
SpineStem Cell
Research
Traumatic
Brain Injury

Submission deadline is March 5th, 2020

Submissions must contain new, previously unpublished material.

All Poster abstracts must be submitted electronically via the SBMT Website.

 

General topics covered at the SBMT Annual Meeting include:

  • Neurosurgery (e.g. Image guided therapy/intervention, brain tumors and intraoperative navigation, nanoneurosurgery, stereotactic radiosurgery/radiotherapy/radiation oncology, minimally invasive therapy, vascular neurosurgery, functional neurosurgery, neurotrauma/military medicine, surgical simulation...)
  • Neurology (e.g. Movement Disorders, neurodegenerative diseases, neuro-oncology, stem cell therapy, neuromodulation, epilepsy, autism, brain and spinal cord function, EEG, MEG,.....)
  • Neuro-oncology (e.g., tumor stem cells, molecular targeting, ablative therapies, clinical trials, tumor treating, fields, personalized medicine, tumor treating fields, radiation oncology).
  • Psychiatry (e.g. Opioid, Addiction, medical imaging for psychiatric conditions such as schizophrenia, depression, PTSD...)
  • Radiology (e.g. fMRI, MEG, PET, Nuclear medicine, MR SPEC, MR-PET, DTI, CT-PET, Focused Ultrasound, SQUID MRI, ultrahigh/low MRI, Neuro-photonics, photo-acoustics, )
  • Neuroscience (e.g. stem cell, molecular neuroscience, image guided mapping of genes, proteomics, genomics, neurophysiology,...)
  • Neuroengineering (e.g. biomaterial & tissue engineering, human brain Machine Interface, brain and spinal cord devices, nanomedicine, extraterrestrial/space medicine & clinical practice, software engineering, electrical and material engineering, aeronautic engineering/space medicine and radiation physics/oncology, microfluidics, MEMS/NEMS as well as robotics)
  • Nano-Bio-Electronics (e.g. integration of Stem cell/cellular therapy with nanotechnology, medical devices and imaging)
  • Spinal Cord (e.g. regeneration, stem cell, imaging, implants and biologics and imaging...)
  • Policy (e.g. healthcare policy issues that affect the treatment delivery, and usage of certain devices/drugs/imaging technologies, FDA regulations and reimbursements, federal and regional regulation impacting healthcare delivery and research funding, Neuroscience-20/G20 Summit Initiative, Brain Technology and Innovation Park...)

The audience includes:

Neuroscientists, neurosurgeons, neurologists, radiologists, pathologists, spine surgeons/orthopedics surgeons, oncologists, chemists, engineers (material, electrical, biomedical, aeronautics and computer), stem cell and molecular biologists, nanotechnologists, pharmacologists and rehabilitation medicine scientists and physicians, psychiatrists and psychologists. nurses, radiology techs, research associates, undergraduate and graduate students are welcomed. The program also covers the great work done by post-doctoral candidates, fellows and world leaders in the field. 

Guidelines

  1. Submit your Poster abstract in the format below

Formatting - Poster abstracts will only be accepted in English to facilitate ease of review and publication.

Sections - Include each section heading, but do not repeat the actual question in the body of your Poster abstract.

SECTION

CLARIFICATION

Title

Limit your title to 30 words or less

Synopsis

A 100-word synopsis of each Poster abstract must be submitted. 
It should include a brief summary of the problem, methods, results, and conclusions. The synopsis must include text only, without equations or images and be without references or citations to items described in the full Poster abstract. 

Target Audience

"Who will benefit from this information?"

Purpose

"Why was this study/research/clinical improvement performed?"

Methods

"How was the problem studied or how did you become aware of the gap in clinical performance?"

Results

"Principal data / statistical analysis / result of making the change"

Discussion

"What is your interpretation of the data / outcome?"

Conclusion

"What is the relevance to future research, training or clinical practice?"

References

At least one reference is strongly suggested, but the total number is not limited.

Submission Guidelines

  • Limit your title to 30 words or less
  • Limit the body of your Poster abstract to 500 words or less (it should fit on one page)
  • The content may not promote the proprietary interests of any commercial entity. Evident bias in favor of a particular product or company is grounds for rejection.
  • Commercial logos may not be included in a Poster, or presented on slides for an accepted presentation.
  • Content must be restricted to pure science, industry issues and operation of devices, Product /company names should be included only to identify specific hardware/software/ peripherals necessary to understand a study, but not to promote proprietary interests (see Point 1)
  • All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
  • All scientific research referred to, reported or used in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection and analysis.

Submitting Your Poster

  • The Poster abstract should include the first author's and all co-authors names and affiliations - institutions.
  • In case you do not yet have a user name, you will be requested to subscribe first.
  • We highly recommend that you become a member and register as soon as possible in order to take advantage of the discounts for registration and hotel accommodations.
  • Submissions are open through March 5th, 2020

The use of standard abbreviations is desirable. A special or unusual abbreviation must be placed (in round brackets) after the first appearance of the word(s) for which it stands. The online Poster abstract submission procedure will not accept Poster abstracts that exceed 500 words (body of the Poster abstract). Color illustrations may be printed in black and white in the Poster book.

For questions regarding the online submission process, please e-mail: joe.bolanos@brainmappingfoundation.org 

Instructions

  • Please follow the instructions on the screen.
  • When finalizing the on-line submission, it is imperative to click the «submit» button for final submission of the Poster abstract; a message will then appear informing you that the file has been submitted successfully. This confirmation of receipt is NOT a notice of acceptance of your Poster abstract.
  • In case no confirmation from SBMT is received, the Poster abstract submitter should contact joe.bolanos@brainmappingfoundation.org within one week after submission of the Poster abstract.
  • Submitting a Poster abstract for presentation does not constitute registration for the conference. Poster presenters must register to attend the congress by following the instructions for online registration.
  • Careful typing and proofreading are essential, as the Poster abstract will be published as submitted.

Regulations

  • The presenting author is obliged to ascertain that all authors are aware of the content of the Poster abstract before submission to SBMT.
  • The presenter and co-authors must identify any financial interest in products or processes described in the Poster abstract.
  • In submitting a Poster abstract, the authors accept that the information to be reported is for exclusive presentation in the session to which the Poster abstract will be assigned if accepted. This information should not be presented at a commercially sponsored satellite symposium.
  • Poster abstracts must be submitted and presented at the conference in English.
  • Notification of receipt and acceptance will be sent only to the corresponding author.

General Information - Authors will be asked to select the following:

  • Topic category: choose the topic category that refers to the main subject of the Poster abstract. The Scientific Committee reserves the right to re-categorize the Poster abstract.
  • Presentation preference: authors should indicate the presentation preference (oral, poster or no preference). Please note that the final decision on the presentation format will be made by the Scientific Committee.
  • Keywords: authors are required to provide 3-6 keywords (start from general keyword for example "Neurosurgery" to more specifics such as "brain tumor" or "nanotechnology").
  • Poster size is maximum 3 (height) x 5 (length) feet.
  • Posters may be disciplined for the duration of the meeting.
  • Poster presenters must at least spend an hour next to their posters to explain the science to the audience.
  • Multiple Poster abstracts could be submitted by an author but each poster should be presented by a different presenter (co-authors) unless it is allowed by the congress secretariat: Bryan.Aroz@Worldbrainmapping.org.
  • The Poster abstract is selected for presentation in a poster format. Poster abstracts are grouped by topic and are displayed throughout the meeting.
  • Oral presentation: Highest ranking Posters/submissions will be selected for oral presentations.

Poster abstract Format

  • Poster abstracts titles should be brief and reflect the content of the research. The title (max. 30 words) is important since it focuses attention (it is the "showcase" for the presentation).
  • Please avoid unusual abbreviation and spell out the abbreviations at least once before reusing it.
  • The on-line Poster abstract submission procedure will not accept Poster abstracts that exceed 500 words.
  • The preferred font is Verdana.

Poster abstract Selection Process
Poster abstracts submitted for presentation will be reviewed by an international panel of experts in the field of the subject.
The Poster abstract will be peer reviewed to ensure fairness and eliminate possible bias and chosen based on ranking by science committee.
Research obviously not yet performed, and results not yet obtained will be banned.
Poster abstracts selected for oral and/or poster presentation should be presented at the meeting. If a selected presenting author cannot attend, he should assign a replacement and inform the SBMT meeting manager of the replacement as soon as possible.